Entry |
|
Name |
Glycosaminoglycan degradation - Homo sapiens (human) |
Class |
Metabolism; Glycan biosynthesis and metabolism
|
Pathway map |
|
Module |
|
Network |
|
Element |
N00610 | Dermatan sulfate degradation |
N00615 | Heparan sulfate degradation |
N00623 | Keratan sulfate degradation |
|
Drug |
D11812 | Pabinafusp alfa (genetical recombination) (JAN) |
D12806 | Tividenofusp alfa (USAN/INN) |
|
Other DBs |
|
Organism |
Homo sapiens (human) [GN: hsa]
|
Gene |
60495 | HPSE2; heparanase 2 (inactive) [KO:K07965] [EC:3.2.1.-] |
|
Compound |
|
Reference |
|
Authors |
Greiling H, Stuhlsatz HW, Cantz M, Gehler J |
Title |
Increased urinary excretion of keratan sulfate in fucosidosis. |
Journal |
|
Reference |
|
Authors |
Fuchs W, Beck M, Kresse H |
Title |
Intralysosomal formation and metabolic fate of N-acetylglucosamine 6-sulfate from keratan sulfate. |
Journal |
|
Related pathway |
hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate |
hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate |
hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin |
|
KO pathway |
|